M. Villanueva

发表

Infectious diseases: Smart combinations to prevent HIV rebound

M. Villanueva, 2018, Nature Reviews Drug Discovery.

Genetics: Working in pairs

M. Villanueva, 2014, Nature Reviews Cancer.

Double boost for mRNA cancer vaccines

M. Villanueva, 2019, Nature Reviews Drug Discovery.

Neurodevelopmental disorders: CRISPR to the rescue

M. Villanueva, 2018, Nature Reviews Drug Discovery.

Imaging: Lighting up tumours

M. Villanueva, 2014, Nature Reviews Clinical Oncology.

Genetics: The evil twin

M. Villanueva, 2015, Nature Reviews Cancer.

Targeted therapies: Regorafenib, the CORRECT way forward or just another GRIDlock?

M. Villanueva, 2013, Nature Reviews Clinical Oncology.

Gastrointestinal cancer: Regorafenib, the CORRECT way forward or just another GRIDlock?

M. Villanueva, 2013, Nature Reviews Gastroenterology &Hepatology.

Imaging: Marking the boundaries

M. Villanueva, 2014, Nature Reviews Cancer.

Microenvironment: Small containers, important cargo

M. Villanueva, 2014, Nature Reviews Cancer.

Fatty acid receptor gives lungs a breather.

M. Villanueva, 2020, Nature reviews. Drug discovery.

Genetics: Splicing the pieces of the chronic lymphocytic leukemia puzzle

M. Villanueva, 2012, Nature Reviews Clinical Oncology.

Urological cancer: An axis for renal cell carcinoma treatment

M. Villanueva, 2012, Nature Reviews Clinical Oncology.

Genetics: Switching on the oestrogen receptor

M. Villanueva, 2013, Nature Reviews Clinical Oncology.

Pancreatic cancer: Standing on the shoulders of mice, making an iMPACT on pancreatic cancer

M. Villanueva, 2013, Nature Reviews Clinical Oncology.

Gastrointestinal cancer: A promising horizon for cediranib?

M. Villanueva, 2012, Nature Reviews Clinical Oncology.

Immunotherapy: Killer combo

M. Villanueva, 2015, Nature Reviews Cancer.

Targeted therapies: Resistance—SRC in the middle

M. Villanueva, 2011, Nature Reviews Clinical Oncology.

Tumour immunology: Eosinophils — T cells' little helpers

M. Villanueva, 2015, Nature Reviews Cancer.

Cell differentiation: Pushing differentiation

M. Villanueva, David Scadden, David Sykes, 2016, Nature Reviews Cancer.

Metabolism: The mitochondria thief

M. Villanueva, 2015, Nature Reviews Cancer.

Haematological malignancies: Double act in follicular lymphoma

M. Villanueva, 2014, Nature Reviews Clinical Oncology.

Anticancer drugs: All roads lead to EZH2 inhibition

M. Villanueva, M. Teresa Villanueva, 2017, Nature Reviews Drug Discovery.

Urological cancer: Are we redeemed from aggressive treatment for prostate cancer?

M. Villanueva, 2012, Nature Reviews Clinical Oncology.

Pharmacogenomics: Know your GPCR mutations (and target them right)

M. Villanueva, 2018, Nature Reviews Drug Discovery.

Gynecological cancer: Home is where the fat is

M. Villanueva, 2012, Nature Reviews Clinical Oncology.

Macrophages get a CAR

M. Villanueva, M. Teresa Villanueva, 2020, Nature Reviews Cancer.

Macrophages get a CAR

M. Villanueva, 2020, Nature Reviews Immunology.

Macrophages get a CAR

M. Villanueva, 2020, Nature Reviews Drug Discovery.

TCR-engineered T cells get personal

M. Villanueva, 2022, Nature Reviews Drug Discovery.

Pediatric oncology: Vinblastine in low-grade glioma

M. Villanueva, 2012, Nature Reviews Clinical Oncology.

Proteomics reveals small molecules' secrets.

M. Villanueva, 2023, Nature reviews. Drug discovery.

Angiogenesis: A sudden rush of blood to the tumour

M. Teresa Villanueva, M. Villanueva, 2015, Nature Reviews Cancer.

Therapeutics: Give it a shock

M. Villanueva, 2015, Nature Reviews Cancer.

Suppressing autoimmunity with mRNA vaccines

M. Villanueva, 2021, Nature Reviews Drug Discovery.

DNA repair: A new tool to target DNA repair

M. Villanueva, 2015, Nature Reviews Cancer.

Targeting cancer-associated neutrophils

M. Villanueva, 2019, Nature Reviews Drug Discovery.

Patient profiling in breast cancer—is knowledge power?

L. Hutchinson, R. Kirk, M. Villanueva, 2011, Nature Reviews Clinical Oncology.

Targeted therapies: Ibrutinib resonates with us

M. Villanueva, 2014, Nature Reviews Clinical Oncology.

Glioblastoma: Will you still fit me when I'm seventy-four?

M. Villanueva, 2012, Nature Reviews Clinical Oncology.

Hematology: Preventing relapse

M. Villanueva, 2011, Nature Reviews Clinical Oncology.

Proteomics: Follow your heat

M. Villanueva, 2014, Nature Reviews Cancer.

Therapeutics: Gastric cancer gets a red carpet treatment

M. Villanueva, 2014, Nature Reviews Cancer.

Skin cancer: In melanoma ulceration, size matters

M. Villanueva, 2012, Nature Reviews Clinical Oncology.

Cancer: LOX does some prepping

M. Villanueva, 2015, Nature Reviews Drug Discovery.

Metastasis: LOX does some prepping

M. Villanueva, 2015, Nature Reviews Cancer.

Repurposing CCR5 inhibitors for stroke recovery

M. Villanueva, 2019, Nature Reviews Drug Discovery.

Targeting cancer-associated neutrophils

M. Villanueva, 2019, Nature reviews. Drug discovery.

New CAR’s bells and whistles

M. Villanueva, 2021, Nature Reviews Drug Discovery.

An mRNA universal vaccine for influenza

M. Villanueva, 2023, Nature Reviews Drug Discovery.

Tumour immunology: TReg cells, more than a suppression problem

M. Villanueva, 2015, Nature Reviews Cancer.

Genetics: When two is worse than one

M. Villanueva, 2011, Nature Reviews Clinical Oncology.

Bispecific antibodies pin down cancer stem cells

M. Villanueva, 2022, Nature Reviews Drug Discovery.

Cell signalling: Breaking down the defenses

M. Villanueva, 2013, Nature Reviews Clinical Oncology.

Rheumatoid arthritis: IL-23 assists the transition from autoimmunity to inflammatory disease

M. Villanueva, 2017, Nature Reviews Rheumatology.

Targeted therapies: Smart tumor, smarter treatment

M. Villanueva, 2012, Nature Reviews Clinical Oncology.

Gastrointestinal cancer: Introducing new steps with a FOxTROT

M. Villanueva, 2012, Nature Reviews Clinical Oncology.

Gastric cancer: A master KLASS in laparoscopic gastrectomy

M. Villanueva, 2014, Nature Reviews Clinical Oncology.

Cancer immunotherapy: STINGing systemically

M. Villanueva, 2018, Nature Reviews Drug Discovery.

Gastrointestinal cancer: The PROs and cons of liver resection in colorectal cancer

M. Villanueva, 2012, Nature Reviews Clinical Oncology.

Tumour-Initiating cells: The cell that rocks the tumour

M. Villanueva, 2016, Nature Reviews. Cancer.

Combination therapy: Update on gastric cancer in East Asia

M. Villanueva, 2011, Nature Reviews Clinical Oncology.

Interfering viral-like particles inhibit SARS-CoV-2 replication

M. Villanueva, 2021, Nature reviews. Drug discovery.

Tumour metabolism: The sugar-free, full-fat diet

M. Villanueva, 2016, Nature Reviews Cancer.

Unmasking cancer cell character

M. Villanueva, 2019, Nature Reviews Cancer.

Lab mice go native

M. Villanueva, 2019, Nature reviews. Drug discovery.

Resistance: How to resist immunotherapy

M. Villanueva, 2016, Nature Reviews. Cancer.

CNS cancer: It takes two to tango

M. Villanueva, 2014, Nature Reviews Clinical Oncology.

Neuro-oncology: It takes two to tango

M. Villanueva, 2014, Nature Reviews Neurology.

Liver disease: Conscious uncoupling in NASH

M. Villanueva, 2017, Nature Reviews Drug Discovery.

Organoids illuminate NAFLD pathogenesis

M. Villanueva, 2023, Nature Reviews Drug Discovery.

Leukaemia: Don't let sleeping cells lie

M. Villanueva, 2016, Nature Reviews. Cancer.

Infectious diseases: Decrypting Cryptosporidium

M. Villanueva, 2017, Nature Reviews Drug Discovery.

Chemotherapy: Have a break

M. Teresa Villanueva, M. Villanueva, 2011, Nature Reviews Clinical Oncology.

Putting a PIN in pancreatic cancer

M. Villanueva, 2021, Nature reviews. Drug discovery.

Rediscovering hygromycin A for Lyme disease treatment

M. Villanueva, 2021, Nature Reviews Drug Discovery.

Epigenetics: Chromatin marks the spot

M. Villanueva, 2015, Nature Reviews Cancer.

Anticancer therapy: Re-educating macrophages

M. Villanueva, 2017, Nature Reviews Drug Discovery.

Targeted therapies: Priming apoptosis

M. Villanueva, 2013, Nature Reviews Clinical Oncology.

Lung cancer: Whack a gli hedgehog

M. Villanueva, 2014, Nature Reviews Clinical Oncology.

APOBEC3A drives resistance

M. Villanueva, 2023, Nature Reviews Drug Discovery.

Targeting EMT in cancer through netrin-1.

M. Villanueva, 2023, Nature reviews. Drug discovery.

Selective activation of Wnt ameliorates idiopathic pulmonary fibrosis

M. Villanueva, 2023, Nature Reviews Drug Discovery.

Base editing rescues hearing in mice

M. Villanueva, 2020, Nature Reviews Drug Discovery.

Liver disease: Conscious uncoupling in NASH

M. Villanueva, 2017 .

Tumorigenesis: Establishing the origin of retinoblastoma

M. Villanueva, 2014, Nature Reviews. Cancer.

Therapeutics: Protective packaging

M. Villanueva, 2014, Nature Reviews Cancer.

Epidemiology: Revisiting family history

M. Villanueva, 2011, Nature Reviews Clinical Oncology.

Cancer: Reset your circadian clock

M. Villanueva, 2018, Nature Reviews Drug Discovery.

Anticancer therapy: Metabolic synthetic lethality

M. Villanueva, 2018, Nature Reviews Drug Discovery.

Tumour immunology: The new midfielders in the tumour microenvironment

M. Villanueva, 2014, Nature Reviews Immunology.

PREP inhibition reduces tau pathology in mouse models

M. Villanueva, 2023, Nature Reviews Drug Discovery.